Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas

Human Pathology

Volumn 37, Issue 8, 2006, Pages 1042-1049

  Sarrió, David ^a   Moreno Bueno, Gema ^a   Sánchez Estévez, Carolina ^a   Bañón Rodríguez, Inmaculada ^a   Hernández Cortés, Ginés ^b   Hardisson, David ^b   Palacios, José ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

APC; Axin; Cadherin; Catenin; Mutations; Ovarian cancer; Wnt signaling

Indexed keywords

ALPHA CATENIN; APC PROTEIN; AXIN; AXIN1 PROTEIN; AXIN2 PROTEIN; BETA CATENIN; CADHERIN; CATENIN; KRAS PROTEIN; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN; PROTEIN; PROTEIN P120; UNCLASSIFIED DRUG; UVOMORULIN;

ALLELE; ARTICLE; CHROMOSOME; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MUCINOUS CARCINOMA; OVARY CARCINOMA; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, ENDOMETRIOID; CATENINS; CELL NUCLEUS; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 5; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 33746049131     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.03.003     Document Type: Article

References (41)

1. In: Tavassoli F.A., and Devilee P. (Eds). WHO Classification of tumors. Tumors of the breast and female genital organs (2003), IARC Press, Lyon
2. Auersperg N., Wong A.S., Choi K.C., et al. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22 (2001) 255-288
3. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84 (1996) 345-357
4. Pötter E., Berwitz C., and Brabant G. The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr Rev 20 (1999) 207-239
5. Ramburan A., and Govender D. Cadherins and catenins in pathology. Curr Diag Pathol 8 (2002) 305-317
6. Hajra K.M., and Fearon E.R. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34 (2002) 255-268
7. Pishvaian M.J., Feltes C.M., Thompson P., et al. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 59 (1999) 947-952
8. Anastasiadis P.Z., and Reynolds A.B. The p120 catenin family: complex roles in adhesion, signaling and cancer. J Cell Sci 113 (2000) 1319-1334
9. Wijnhoven B.P.L., Dinjens W.N.M., and Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 87 (2000) 992-1005
10. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653 (2003) 1-24
11. Palacios J., and Gamallo C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian tumors. Cancer Res 58 (1998) 1344-1347
12. Wu R., Zhai Y., Fearon E.R., et al. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 61 (2001) 8247-8255
13. Gamallo C., Palacios J., Moreno G., et al. β-catenin expression pattern in stage I and II ovarian carcinomas. Am J Pathol 155 (1999) 527-536
14. Moreno-Bueno G., Gamallo C., Pérez-Gallego L., et al. β-catenin expression pattern, β-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 10 (2001) 116-122
15. Satoh S., Daigo Y., Furukawa Y., et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24 (2000) 245-250
16. Liu W., Dong X., Mai M., et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26 (2000) 146-147
17. Gamallo C., Palacios J., Suarez A., et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142 (1993) 983-987
18. Sarrió D., Moreno-Bueno G., Hardisson D., et al. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression, and microsatellite instability. Int J Cancer 106 (2003) 208-215
19. Moreno-Bueno G., Hardisson D., Sanchez C., et al. Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene 21 (2002) 7981-7990
20. Catasús L., Bussaglia E., Rodríguez I., et al. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol 35 (2004) 1360-1368
21. Peralta-Soler A., Knudsen K.A., Tecson-Miguel A., et al. Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol 28 (1997) 734-739
22. Faleiro-Rodrigues C., Macedo-Pinto I., Pereira D., et al. Association of E-cadherin and β-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas. Hum Pathol 35 (2004) 663-669
23. Roveri-Marques F., Fonsechi-Carvasan G.A., Andrade L.A., et al. Immunohistochemical patterns for α- and β-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol 94 (2004) 16-24
24. Sundfeldt K. Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule. Mol Cell Endocrinol 202 (2003) 89-96
25. Ong A., Maines-Bandiera S.L., Roskelley C.D., et al. An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int J Cancer 85 (2000) 430-437
26. Wong A.S., Maines-Bandiera S.L., Rosen B., et al. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer 81 (1999) 180-188
27. Davies B.R., Worsley S.D., and Ponder B.A.J. Expression of E-cadherin, α-catenin and β-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology 32 (1998) 69-80
28. Nieman M.T., Prudoff R.S., Johnson K.R., et al. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147 (1999) 631-644
29. Hazan R.B., Phillips G.R., Qiao R.F., et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148 (2000) 779-790
30. Li G., Satyamoorthy K., and Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61 (2001) 3819-3825
31. Patel I.S., Madan P., Getsios S., et al. Cadherin switching in ovarian cancer progression. Int J Cancer 106 (2003) 172-177
32. Shibata T., Ochiai A., Gotoh M., et al. Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer. Cancer Lett 99 (1996) 147-153
33. Elloul S., Elstrand M.B., Nesland J.M., et al. Snail, slug, and smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103 (2005) 1631-1643
34. Sato T., Saito H., Morita R., et al. Allelotype of human ovarian cancer. Cancer Res 51 (1991) 5118-5122
35. Kawakami M., Staub J., Cliby W., et al. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol 15 (1999) 715-720
36. Imai T., Horiuchi A., Shiozawa T., et al. Elevated expression of E-cadherin and α-, β-, and γ-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 35 (2004) 1469-1476
37. Reynolds A.B., and Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 23 (2004) 7947-7956
38. Thoreson M.A., and Reynolds A.B. Altered expression of the catenin p120 in human cancer: implications for tumor progression. Differentiation 70 (2002) 583-589
39. Allan G.J., Cottrell S., Trowsdale J., et al. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22. Hum Mutat 3 (1994) 283-291
40. Karbova E., Davidson B., Metodiev K., et al. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma. Int J Surg Pathol 10 (2002) 175-180
41. Espada J., Perez-Moreno M., Braga V.M., et al. H-ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J Cell Biol 146 (1999) 967-980